These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9034415)

  • 1. Algorithms used in adverse drug event reports: a comparative study.
    Frick PA; Cohen LG; Rovers JP
    Ann Pharmacother; 1997 Feb; 31(2):164-7. PubMed ID: 9034415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quality of published adverse drug event reports.
    Kelly WN
    Ann Pharmacother; 2003 Dec; 37(12):1774-8. PubMed ID: 14632590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making Sense of Pharmacovigilance and Drug Adverse Event Reporting: Comparative Similarity Association Analysis Using AI Machine Learning Algorithms in Dogs and Cats.
    Xu X; Mazloom R; Goligerdian A; Staley J; Amini M; Wyckoff GJ; Riviere J; Jaberi-Douraki M
    Top Companion Anim Med; 2019 Dec; 37():100366. PubMed ID: 31837760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a computer-based adverse-drug-event monitor.
    Hwang SH; Lee S; Koo HK; Kim Y
    Am J Health Syst Pharm; 2008 Dec; 65(23):2265-72. PubMed ID: 19020194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
    Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
    Trials; 2015 Jan; 16():2. PubMed ID: 25572800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incident reporting system does not detect adverse drug events: a problem for quality improvement.
    Cullen DJ; Bates DW; Small SD; Cooper JB; Nemeskal AR; Leape LL
    Jt Comm J Qual Improv; 1995 Oct; 21(10):541-8. PubMed ID: 8556111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential risks and prevention, Part 1: Fatal adverse drug events.
    Kelly WN
    Am J Health Syst Pharm; 2001 Jul; 58(14):1317-24. PubMed ID: 11471479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of verbal protocol analysis for identification of ADE signals.
    Phansalkar S; Patel VL; Hoffman JM; Hurdle JF
    AMIA Annu Symp Proc; 2006; 2006():1063. PubMed ID: 17238682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detecting adverse drug events during the hospital stay].
    Berga Culleré C; Gorgas Torner MQ; Altimiras Ruiz J; Tuset Creus M; Besalduch Martín M; Capdevila Sunyer M; Torres Gubert M; Casajoana Cortinas MT; Baró Sabaté E; Fernández Solà JR; Moron i Besolí A; Odena Estradé E; Serrais Benavente J; Vitales Farrero MT; Codina Jané C
    Farm Hosp; 2009; 33(6):312-23. PubMed ID: 20038390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of two methods to assess causality of adverse drug reactions].
    Kyonen M; Folatre I; Lagos X; Vargas S
    Rev Med Chil; 2015 Jul; 143(7):880-6. PubMed ID: 26361025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RADARx: Recognizing, Assessing, and Documenting Adverse Rx events.
    Brown S; Black K; Mrochek S; Wood A; Bess T; Cobb J; Francis J
    Proc AMIA Symp; 2000; ():101-5. PubMed ID: 11079853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():101-115. PubMed ID: 30409335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting Adverse Drug Events: Accuracy and Generalizability.
    Walter SR; Gallego B
    Ther Innov Regul Sci; 2019 Nov; 53(6):795-796. PubMed ID: 30595045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a clinical data repository to estimate the frequency and costs of adverse drug events.
    Einbinder JS; Scully K
    Proc AMIA Symp; 2001; ():154-8. PubMed ID: 11833476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug event profile associated with pregabalin among patients with and without cancer: analysis of a spontaneous reporting database.
    Kose E
    J Clin Pharm Ther; 2018 Aug; 43(4):543-549. PubMed ID: 29574893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
    Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
    J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients.
    Kunac DL; Reith DM; Kennedy J; Austin NC; Williams SM
    Qual Saf Health Care; 2006 Jun; 15(3):196-201. PubMed ID: 16751470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency department visits caused by adverse drug events: results of a French survey.
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X; Lapostolle F; Borron SW; Adnet F;
    Drug Saf; 2007; 30(1):81-8. PubMed ID: 17194173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Drug Event Rate in Israeli Hospitals: Validation of an International Trigger Tool and an International Comparison Study.
    Zimlichman E; Gueta I; Daliyot D; Ziv A; Oberman B; Hochman O; Tamir O; Tal O; Loebstein R
    Isr Med Assoc J; 2018 Nov; 20(11):665-669. PubMed ID: 30430793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.